Fiera Capital (Canada)
KRTX

Fiera Capital (Canada)’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Fiera Capital (Canada)’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-237,656
Closed -$75.2M – 543
2023
Q4 		$75.2M Buy
237,656
+199
+0.1% +$38.7K 0.23% 60
2023
Q3 		$40.2M Buy
237,457
+4,697
+2% +$883K 0.13% 98
2023
Q2 		$50.5M Sell
232,760
-5,418
-2% -$1.16M 0.15% 82
2023
Q1 		$43.3M Buy
238,178
+75,452
+46% +$14.4M 0.13% 89
2022
Q4 		$32M Buy
162,726
+61,086
+60% +$13.1M 0.1% 109
2022
Q3 		$20.7M Buy
+101,640
New +$20.6M 0.07% 135

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Fiera Capital (Canada)'s KRTX Position: Q1 2024 in Review

Fiera Capital (Canada) sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 237,656 shares — an estimated $75.2M sold.

Fiera Capital (Canada) first reported a position in KRTX in Q3 2022 and held it in 6 quarters. The position peaked at $75.2M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Fiera Capital (Canada) reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Fiera Capital (Canada) sold 237,656 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $75.2M.
  • Fiera Capital (Canada) first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
  • Fiera Capital (Canada)'s Karuna Therapeutics, Inc. Common Stock position peaked at $75.2M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Fiera Capital (Canada)'s 13F filing for Q1 2024, filed 1 May 2024.